LEXINGTON, Mass.--(BUSINESS WIRE)--Imprivata®, a leading global provider of healthcare IT security solutions, today announced a program to enable customers using the Citrix Single Sign-On (SSO) feature to seamlessly migrate to Imprivata OneSign® Single Sign-On to enhance security and increase workflow efficiency. Organizations in healthcare and other industries that currently rely on Citrix to support Windows application SSO for XenDesktop® and XenApp® platforms are eligible to participate in Imprivata’s migration program to quickly and cost-effectively implement OneSign. Imprivata will be available to discuss details of this program and to showcase the features and benefits of OneSign in booth #502 during Citrix Synergy™ (May 22-24, 2013 at the Anaheim Convention Center in Anaheim, Calif.).
“Imprivata continues to focus on bringing solutions to market that deliver fast, secure access to applications and information while increasing workflow efficiency, boosting productivity and reducing cost. Citrix is a tremendous partner in helping us optimize these capabilities for virtual environments with XenDesktop and XenApp as well as on next-generation thin and zero client platforms,” said Geoff Hogan, senior vice president of corporate business development at Imprivata. “We welcome the opportunity to work with Citrix customers worldwide to help them quickly and cost-effectively migrate to Imprivata OneSign.”
Verified as Citrix Ready® for XenDesktop and XenApp, Imprivata OneSign is a complete authentication and SSO solution designed to simplify secure access to mission-critical applications and information to increase workflow efficiency, boost productivity and reduce cost. Imprivata OneSign enables No Click Access™ to extend these benefits to virtual computing environments, allowing end users to quickly and securely access their personal desktop from any location within the organization. Imprivata also leverages its OneSign ProveID Embedded software layer to support leading system-on-chip (SoC) designs, incorporating Citrix HDX™, to directly integrate with leading thin- and zero-client solutions from Dell Wyse, HP, Samsung, IGEL, NComputing and other vendors to provide native authentication.
“SSO is an essential security and convenience feature for Citrix customers that helps them maintain control of corporate information without sacrificing workflow efficiencies or productivity in virtual computing environments,” said Calvin Hsu, vice president, product marketing, Desktops and Apps, at Citrix. “With Imprivata, customers using Citrix SSO technology will have access to a solution that maintains the continuity of critical workflows in XenDesktop and XenApp environments, including access from thin- and zero-client devices. Imprivata OneSign is a proven SSO and authentication management solution for all Citrix environments, and we encourage customers to work with Imprivata to take advantage of this migration program to extend their desktop virtualization solutions to the latest platforms.”
For more information about how Imprivata OneSign enables No Click Access for Citrix XenDesktop and Citrix XenApp, please visit: http://www.imprivata.com/products-and-solutions/desktop-virtualization/onesign-virtual-desktop-access-for-citrix.
For customers interested in more information about Imprivata’s migration program and/or to participate, please send an email to sales@imprivata.com.
About Imprivata
Imprivata, the leader in healthcare IT security, enables secure access and collaboration for two million healthcare users worldwide. As the #1 independent provider of single sign-on and access management solutions for healthcare and other regulated industries, Imprivata OneSign® Single Sign-On is exclusively endorsed by the American Hospital Association (AHA) and recognized by Gartner and KLAS. Imprivata Cortext™ is the leading free HIPAA compliant text messaging solution for healthcare. Headquartered in Lexington, Massachusetts, Imprivata serves 1,300 hospitals in partnership with over 200 EMR and technology infrastructure vendors around the world. For more information, please visit www.imprivata.com.
Connect with Imprivata:
Twitter https://twitter.com/Imprivata
Facebook
www.facebook.com/Imprivata
LinkedIn
www.linkedin.com/company/imprivata
Imprivata’s
corporate blog http://www.imprivata.com/blog
All Imprivata products are trademarks of Imprivata, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.
